Skip to main content
Premium Trial:

Request an Annual Quote

Invitrogen, SuperArray Bioscience

Premium

Invitrogen will launch a proteome microarray product at BIO 2004 in San Francisco this week, the company announced said. In addition, the company will detail plans for developing subsets of the human proteome with proteins grouped by family and function.


SuperArray Bioscience last week launched its RT(2) Real-Time gene expression assay kits for every gene in the human, mouse, and rat genomes. These quantitative gene expression assays are intended for genome-wide disease characterization, pathway elucidation, functional studies, and in the basic research of human disease, the company said in a statement. Additionally, the kits can be applied for the independent verification of DNA microarray data.

Each kit includes gene-specific PCR primers designed with proprietary, experimentally verified design algorithms. The PCR primers are optimized for real-time PCR and SYBR Green detection. Also included is a specially optimized master mix for real-time PCR.

The Scan

Unwrapping Mummies' Faces

LiveScience reports that Parabon NanoLabs researchers have reconstructed how three Egyptian mummies may have looked.

Study on Hold

The Spectrum 10K study has been put on hold due to a backlash, leading the researchers to conduct consultations with the autism community, Nature News reports.

Others Out There Already

Reuters reports that Sanofi is no longer developing an mRNA-based vaccine for SARS-CoV-2.

PNAS Papers on GWAS False Discovery, PRAMEF2 Role in Tumorigenesis, RNA Virus Reverse Genetics

In PNAS this week: strategy to account for GWAS false-discovery rates, role of PRAMEF2 in cancer development, and more.